Ralph Bloomfield

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Certolizumab Pegol for the Treatment of Crohn's Disease

William J. Sandborn, Brian G. Feagan, S Stoĭnov et al. · New England Journal of Medicine · 2007 · 1.1K citations · Full text

Maintenance Therapy with Certolizumab Pegol for Crohn's Disease

Stefan Schreiber, Mani Khaliq-Kareemi, Ian C. Lawrance et al. · New England Journal of Medicine · 2007 · 1K citations

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

Stefan Schreiber, Jean‐Frédéric Colombel, Ralph Bloomfield et al. · The American Journal of Gastroenterology · 2010 · 230 citations